Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 23, 2017

DrugPatentWatch Database Preview

METHADONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Methadone Hydrochloride, and when can generics launch?

Methadone Hydrochloride is a drug marketed by Aurolife Pharma Llc, Vistapharm, Roxane, Mallinckrodt, Mylan Institutional, The Pharmanetwork, Sandoz, Mallinckrodt Inc, West-ward Pharms Int, and Corepharma. and is included in nineteen NDAs.

The generic ingredient in METHADONE HYDROCHLORIDE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.

Summary for Tradename: METHADONE HYDROCHLORIDE

Patents:0
Applicants:10
NDAs:19
Suppliers / Packagers: see list17
Bulk Api Vendors: see list11
Clinical Trials: see list1,075
Patent Applications: see list1,923
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:METHADONE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: METHADONE HYDROCHLORIDE

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurolife Pharma Llc
METHADONE HYDROCHLORIDE
methadone hydrochloride
TABLET;ORAL203502-001Aug 31, 2015AARXNoNo► Subscribe► Subscribe
Roxane
METHADONE HYDROCHLORIDE
methadone hydrochloride
TABLET;ORAL074081-001Apr 28, 1995DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
METHADONE HYDROCHLORIDE
methadone hydrochloride
SOLUTION;ORAL087393-001Approved Prior to Jan 1, 1982AARXNoYes► Subscribe► Subscribe
Mallinckrodt
METHADONE HYDROCHLORIDE
methadone hydrochloride
TABLET;ORAL040517-001Apr 27, 2004AARXNoNo► Subscribe► Subscribe
Vistapharm
METHADONE HYDROCHLORIDE
methadone hydrochloride
SOLUTION;ORAL090707-002Jun 30, 2010AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot